Related Experiment Video
Updated: Jun 19, 2026

03:22
Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion
Published on: November 10, 2023
EXPERIMENTAL PLEURISY-RESOLUTION OF A FIBRINOUS EXUDATE
1Rockefeller Institute for Medical Research, New York.
The Journal of Experimental Medicine
|October 30, 2009
Summary
This study shows that enzymes from white blood cells (leukocytes) help break down fibrin in pleurisy. Carbon dioxide appears to activate these enzymes, aiding in the resolution of inflammatory exudates.
Area of Science:
- Biochemistry
- Cell Biology
- Pathology
Background:
- Fibrinous pleurisy, induced by turpentine in dogs, serves as a model to study enzyme activity in resolving inflammatory exudates.
- The inflammatory process involves fluid accumulation, fibrin deposition, and subsequent resolution over several weeks, with varying cellular and enzymatic profiles.
Purpose of the Study:
- To investigate the role of leukocyte enzymes in the resolution of fibrinous exudates in pleurisy.
- To characterize the enzymatic activity and cellular changes during different stages of pleurisy resolution.
Main Methods:
- Induction of fibrinous pleurisy in dogs using turpentine injection into the pleural cavity.
- Collection and analysis of pleural fluid and fibrin exudates at various time points post-induction.
- In vitro digestion assays of fibrin exudates in acidic and alkaline media, with and without added carbon dioxide.
Main Results:
- Fibrin exudates showed enzymatic digestion in both acidic and alkaline media during the early inflammatory stage, correlating with the presence of polynuclear leukocytes and leucoprotease.
- In later stages, digestion primarily occurred in acidic conditions, with mononuclear cells and an acid-digesting enzyme present.
- Proteolytic digestion products (peptone, albumose) appeared after three days.
- Exudate fluid inhibited leukocyte enzymes, but carbon dioxide was found to accelerate fibrin digestion, even in the presence of serum.
Conclusions:
- Leukocyte enzymes play a crucial role in the resolution of fibrinous pleurisy.
- The activity of these enzymes changes during the inflammatory process, with different enzymes predominating in early and late stages.
- Carbon dioxide is identified as a potential in vivo activator of the acid-digesting enzyme, facilitating fibrinolysis and resolution of the exudate.
Related Concept Videos
Pleural Effusion II: Symptoms and Management
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pleural Effusion I: Introduction
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
Pleura of the Lungs
The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
Inflammatory Response II: Inflammatory Exudate and Tissue Repair
The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the exudate's...
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the exudate's...
Pleural Disorders: Types and Brief Description
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
